Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bup/Nx Facilitated Rehab for Opioid Dependent Adolescents
NCT00078130Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2003
- Primary completion
- Jan 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of buprenorphine and naloxone in opioid use disorder (OUD) (2 arms), sponsored by University of Pennsylvania. Primary endpoint: Opioid-positive urine test results at 12 weeks. Started Jul 2003; status: completed.
02
Drugs
buprenorphinenaloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00078130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00078130.